カテゴリ： 世界, 医療/バイオ, QYResearch

インターベンショナル腫瘍アブレーションの世界市場2023年：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション

■ 英語タイトル：Global Interventional Tumor Ablation Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7487）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7487
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[インターベンショナル腫瘍アブレーションの世界市場2023年：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はインターベンショナル腫瘍アブレーションのグローバル市場について調査・分析し、世界のインターベンショナル腫瘍アブレーション市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション）、用途別セグメント分析（病院＆診療所、外来手術センター、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boston Scientific Corporation、Johnson & Johnson、Medtronic Plc、Varian Medical Systems、EDAP TMS S.A.、AngioDynamics、CASCINATION AG、Merit Medical Systems、STARmed、Biomedical Srlなどが含まれています。インターベンショナル腫瘍アブレーションのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、インターベンショナル腫瘍アブレーション市場規模を算出する際に考慮しました。

・インターベンショナル腫瘍アブレーション市場の概要
- インターベンショナル腫瘍アブレーションの種類別セグメント
- 世界のインターベンショナル腫瘍アブレーション市場規模：タイプ別分析（高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション）
- インターベンショナル腫瘍アブレーションの用途別セグメント
- 世界のインターベンショナル腫瘍アブレーション市場規模：用途別分析（病院＆診療所、外来手術センター、その他）
- 世界のインターベンショナル腫瘍アブレーション市場規模予測（2018年-2029年）

・インターベンショナル腫瘍アブレーション市場の成長トレンド
- インターベンショナル腫瘍アブレーションの地域別市場規模（2018年-2029年）
- インターベンショナル腫瘍アブレーション市場ダイナミクス
- インターベンショナル腫瘍アブレーションの業界動向
- インターベンショナル腫瘍アブレーション市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション
- 世界のインターベンショナル腫瘍アブレーションのタイプ別市場規模（2018年-2023年）
- 世界のインターベンショナル腫瘍アブレーションのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院＆診療所、外来手術センター、その他
- 世界のインターベンショナル腫瘍アブレーションの用途別市場規模（2018年-2023年）
- 世界のインターベンショナル腫瘍アブレーションの用途別市場規模（2024年-2029年）

・インターベンショナル腫瘍アブレーションの地域別市場規模
- 北米のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 米国のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- ヨーロッパのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- アジア太平洋のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 中国のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 日本のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 韓国のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- インドのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- オーストラリアのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 中南米のインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）
- 中東・アフリカのインターベンショナル腫瘍アブレーション市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Boston Scientific Corporation、Johnson & Johnson、Medtronic Plc、Varian Medical Systems、EDAP TMS S.A.、AngioDynamics、CASCINATION AG、Merit Medical Systems、STARmed、Biomedical Srl

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Interventional Tumor Ablation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Interventional Tumor Ablation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Interventional Tumor Ablation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Interventional Tumor Ablation in Hospitals And Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Interventional Tumor Ablation include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems and STARmed, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Interventional Tumor Ablation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Tumor Ablation.
The Interventional Tumor Ablation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Interventional Tumor Ablation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Tumor Ablation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boston Scientific Corporation
Johnson & Johnson
Medtronic Plc
Varian Medical Systems
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems
STARmed
Biomedical Srl
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Segment by Application
Hospitals And Clinics
Outpatient Surgery Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Tumor Ablation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Tumor Ablation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Irreversible Electroporation Ablation
1.3 Market by Application
1.3.1 Global Interventional Tumor Ablation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals And Clinics
1.3.3 Outpatient Surgery Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Tumor Ablation Market Perspective (2018-2029)
2.2 Interventional Tumor Ablation Growth Trends by Region
2.2.1 Global Interventional Tumor Ablation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Interventional Tumor Ablation Historic Market Size by Region (2018-2023)
2.2.3 Interventional Tumor Ablation Forecasted Market Size by Region (2024-2029)
2.3 Interventional Tumor Ablation Market Dynamics
2.3.1 Interventional Tumor Ablation Industry Trends
2.3.2 Interventional Tumor Ablation Market Drivers
2.3.3 Interventional Tumor Ablation Market Challenges
2.3.4 Interventional Tumor Ablation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Tumor Ablation Players by Revenue
3.1.1 Global Top Interventional Tumor Ablation Players by Revenue (2018-2023)
3.1.2 Global Interventional Tumor Ablation Revenue Market Share by Players (2018-2023)
3.2 Global Interventional Tumor Ablation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Interventional Tumor Ablation Revenue
3.4 Global Interventional Tumor Ablation Market Concentration Ratio
3.4.1 Global Interventional Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Tumor Ablation Revenue in 2022
3.5 Interventional Tumor Ablation Key Players Head office and Area Served
3.6 Key Players Interventional Tumor Ablation Product Solution and Service
3.7 Date of Enter into Interventional Tumor Ablation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Tumor Ablation Breakdown Data by Type
4.1 Global Interventional Tumor Ablation Historic Market Size by Type (2018-2023)
4.2 Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2029)
5 Interventional Tumor Ablation Breakdown Data by Application
5.1 Global Interventional Tumor Ablation Historic Market Size by Application (2018-2023)
5.2 Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Interventional Tumor Ablation Market Size (2018-2029)
6.2 North America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Interventional Tumor Ablation Market Size by Country (2018-2023)
6.4 North America Interventional Tumor Ablation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Tumor Ablation Market Size (2018-2029)
7.2 Europe Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Interventional Tumor Ablation Market Size by Country (2018-2023)
7.4 Europe Interventional Tumor Ablation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Tumor Ablation Market Size (2018-2029)
8.2 Asia-Pacific Interventional Tumor Ablation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2023)
8.4 Asia-Pacific Interventional Tumor Ablation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Tumor Ablation Market Size (2018-2029)
9.2 Latin America Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Interventional Tumor Ablation Market Size by Country (2018-2023)
9.4 Latin America Interventional Tumor Ablation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Tumor Ablation Market Size (2018-2029)
10.2 Middle East & Africa Interventional Tumor Ablation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2023)
10.4 Middle East & Africa Interventional Tumor Ablation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific Corporation
11.1.1 Boston Scientific Corporation Company Detail
11.1.2 Boston Scientific Corporation Business Overview
11.1.3 Boston Scientific Corporation Interventional Tumor Ablation Introduction
11.1.4 Boston Scientific Corporation Revenue in Interventional Tumor Ablation Business (2018-2023)
11.1.5 Boston Scientific Corporation Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Interventional Tumor Ablation Introduction
11.2.4 Johnson & Johnson Revenue in Interventional Tumor Ablation Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 Medtronic Plc
11.3.1 Medtronic Plc Company Detail
11.3.2 Medtronic Plc Business Overview
11.3.3 Medtronic Plc Interventional Tumor Ablation Introduction
11.3.4 Medtronic Plc Revenue in Interventional Tumor Ablation Business (2018-2023)
11.3.5 Medtronic Plc Recent Development
11.4 Varian Medical Systems
11.4.1 Varian Medical Systems Company Detail
11.4.2 Varian Medical Systems Business Overview
11.4.3 Varian Medical Systems Interventional Tumor Ablation Introduction
11.4.4 Varian Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.4.5 Varian Medical Systems Recent Development
11.5 EDAP TMS S.A.
11.5.1 EDAP TMS S.A. Company Detail
11.5.2 EDAP TMS S.A. Business Overview
11.5.3 EDAP TMS S.A. Interventional Tumor Ablation Introduction
11.5.4 EDAP TMS S.A. Revenue in Interventional Tumor Ablation Business (2018-2023)
11.5.5 EDAP TMS S.A. Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Detail
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Tumor Ablation Introduction
11.6.4 AngioDynamics Revenue in Interventional Tumor Ablation Business (2018-2023)
11.6.5 AngioDynamics Recent Development
11.7 CASCINATION AG
11.7.1 CASCINATION AG Company Detail
11.7.2 CASCINATION AG Business Overview
11.7.3 CASCINATION AG Interventional Tumor Ablation Introduction
11.7.4 CASCINATION AG Revenue in Interventional Tumor Ablation Business (2018-2023)
11.7.5 CASCINATION AG Recent Development
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Company Detail
11.8.2 Merit Medical Systems Business Overview
11.8.3 Merit Medical Systems Interventional Tumor Ablation Introduction
11.8.4 Merit Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023)
11.8.5 Merit Medical Systems Recent Development
11.9 STARmed
11.9.1 STARmed Company Detail
11.9.2 STARmed Business Overview
11.9.3 STARmed Interventional Tumor Ablation Introduction
11.9.4 STARmed Revenue in Interventional Tumor Ablation Business (2018-2023)
11.9.5 STARmed Recent Development
11.10 Biomedical Srl
11.10.1 Biomedical Srl Company Detail
11.10.2 Biomedical Srl Business Overview
11.10.3 Biomedical Srl Interventional Tumor Ablation Introduction
11.10.4 Biomedical Srl Revenue in Interventional Tumor Ablation Business (2018-2023)
11.10.5 Biomedical Srl Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Interventional Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Radiofrequency Ablation
Table 3. Key Players of Microwave Ablation
Table 4. Key Players of Cryoablation
Table 5. Key Players of Irreversible Electroporation Ablation
Table 6. Global Interventional Tumor Ablation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Interventional Tumor Ablation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Interventional Tumor Ablation Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Interventional Tumor Ablation Market Share by Region (2018-2023)
Table 10. Global Interventional Tumor Ablation Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Interventional Tumor Ablation Market Share by Region (2024-2029)
Table 12. Interventional Tumor Ablation Market Trends
Table 13. Interventional Tumor Ablation Market Drivers
Table 14. Interventional Tumor Ablation Market Challenges
Table 15. Interventional Tumor Ablation Market Restraints
Table 16. Global Interventional Tumor Ablation Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Interventional Tumor Ablation Market Share by Players (2018-2023)
Table 18. Global Top Interventional Tumor Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Tumor Ablation as of 2022)
Table 19. Ranking of Global Top Interventional Tumor Ablation Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Interventional Tumor Ablation Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Interventional Tumor Ablation Product Solution and Service
Table 23. Date of Enter into Interventional Tumor Ablation Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Interventional Tumor Ablation Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Interventional Tumor Ablation Revenue Market Share by Type (2018-2023)
Table 27. Global Interventional Tumor Ablation Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Interventional Tumor Ablation Revenue Market Share by Type (2024-2029)
Table 29. Global Interventional Tumor Ablation Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Interventional Tumor Ablation Revenue Market Share by Application (2018-2023)
Table 31. Global Interventional Tumor Ablation Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Interventional Tumor Ablation Revenue Market Share by Application (2024-2029)
Table 33. North America Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Interventional Tumor Ablation Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Interventional Tumor Ablation Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Interventional Tumor Ablation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Interventional Tumor Ablation Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Interventional Tumor Ablation Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Interventional Tumor Ablation Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Interventional Tumor Ablation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Interventional Tumor Ablation Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Interventional Tumor Ablation Market Size by Country (2024-2029) & (US$ Million)
Table 48. Boston Scientific Corporation Company Detail
Table 49. Boston Scientific Corporation Business Overview
Table 50. Boston Scientific Corporation Interventional Tumor Ablation Product
Table 51. Boston Scientific Corporation Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 52. Boston Scientific Corporation Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Interventional Tumor Ablation Product
Table 56. Johnson & Johnson Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Medtronic Plc Company Detail
Table 59. Medtronic Plc Business Overview
Table 60. Medtronic Plc Interventional Tumor Ablation Product
Table 61. Medtronic Plc Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 62. Medtronic Plc Recent Development
Table 63. Varian Medical Systems Company Detail
Table 64. Varian Medical Systems Business Overview
Table 65. Varian Medical Systems Interventional Tumor Ablation Product
Table 66. Varian Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 67. Varian Medical Systems Recent Development
Table 68. EDAP TMS S.A. Company Detail
Table 69. EDAP TMS S.A. Business Overview
Table 70. EDAP TMS S.A. Interventional Tumor Ablation Product
Table 71. EDAP TMS S.A. Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 72. EDAP TMS S.A. Recent Development
Table 73. AngioDynamics Company Detail
Table 74. AngioDynamics Business Overview
Table 75. AngioDynamics Interventional Tumor Ablation Product
Table 76. AngioDynamics Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 77. AngioDynamics Recent Development
Table 78. CASCINATION AG Company Detail
Table 79. CASCINATION AG Business Overview
Table 80. CASCINATION AG Interventional Tumor Ablation Product
Table 81. CASCINATION AG Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 82. CASCINATION AG Recent Development
Table 83. Merit Medical Systems Company Detail
Table 84. Merit Medical Systems Business Overview
Table 85. Merit Medical Systems Interventional Tumor Ablation Product
Table 86. Merit Medical Systems Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 87. Merit Medical Systems Recent Development
Table 88. STARmed Company Detail
Table 89. STARmed Business Overview
Table 90. STARmed Interventional Tumor Ablation Product
Table 91. STARmed Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 92. STARmed Recent Development
Table 93. Biomedical Srl Company Detail
Table 94. Biomedical Srl Business Overview
Table 95. Biomedical Srl Interventional Tumor Ablation Product
Table 96. Biomedical Srl Revenue in Interventional Tumor Ablation Business (2018-2023) & (US$ Million)
Table 97. Biomedical Srl Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interventional Tumor Ablation Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Interventional Tumor Ablation Market Share by Type: 2022 VS 2029
Figure 3. Radiofrequency Ablation Features
Figure 4. Microwave Ablation Features
Figure 5. Cryoablation Features
Figure 6. Irreversible Electroporation Ablation Features
Figure 7. Global Interventional Tumor Ablation Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Interventional Tumor Ablation Market Share by Application: 2022 VS 2029
Figure 9. Hospitals And Clinics Case Studies
Figure 10. Outpatient Surgery Center Case Studies
Figure 11. Other Case Studies
Figure 12. Interventional Tumor Ablation Report Years Considered
Figure 13. Global Interventional Tumor Ablation Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Interventional Tumor Ablation Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Interventional Tumor Ablation Market Share by Region: 2022 VS 2029
Figure 16. Global Interventional Tumor Ablation Market Share by Players in 2022
Figure 17. Global Top Interventional Tumor Ablation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Tumor Ablation as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Interventional Tumor Ablation Revenue in 2022
Figure 19. North America Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Interventional Tumor Ablation Market Share by Country (2018-2029)
Figure 21. United States Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Interventional Tumor Ablation Market Share by Country (2018-2029)
Figure 25. Germany Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Interventional Tumor Ablation Market Share by Region (2018-2029)
Figure 33. China Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Interventional Tumor Ablation Market Share by Country (2018-2029)
Figure 41. Mexico Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Interventional Tumor Ablation Market Share by Country (2018-2029)
Figure 45. Turkey Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Interventional Tumor Ablation Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Boston Scientific Corporation Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 49. Medtronic Plc Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 50. Varian Medical Systems Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 51. EDAP TMS S.A. Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 52. AngioDynamics Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 53. CASCINATION AG Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 54. Merit Medical Systems Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 55. STARmed Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 56. Biomedical Srl Revenue Growth Rate in Interventional Tumor Ablation Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 腫瘍アブレーション装置の世界市場2023年：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、その他
  • 腫瘍細胞分離キットの世界市場2023年：乳癌腫瘍細胞分離、黒色腫腫瘍細胞分離、卵巣癌腫瘍細胞分離、その他
  • 世界の心臓外科及びインターベンショナル心臓病学デバイス市場2022年：市場規模予測（～2028年）
  • ナビゲーション＆位置決めマイクロ波アブレーションシステムのグローバル市場展望 2023年-2029年：直進型、穿刺型
  • 心臓パルス電界アブレーションシステムのグローバル市場展望 2023年-2029年：可逆的エレクトロポレーション、不可逆的エレクトロポレーション技術
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7487 )"インターベンショナル腫瘍アブレーションの世界市場2023年：高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、不可逆エレクトロポレーションアブレーション" (英文：Global Interventional Tumor Ablation Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。